film-coated

DRUG2 trials

Sponsors

NewAmsterdam Pharma B.V., Dr. Willmar Schwabe GmbH & Co. KG

Conditions

COGNITIVE IMPAIRMENT ASSOCIATED WITH POST-COVID-19 SYNDROMEatherosclerotic heart and blood vessel disease (the narrowing of arteries from buildup of plague

Phase 2

A RANDOMIZED, PLACEBO-CONTROLLED, TRIPLE-BLIND CLINICAL TRIAL TO INVESTIGATE TREATMENT EFFECTS AND SAFETY OF GINKGO BILOBA EXTRACT EGB 761® IN PARTICIPANTS WITH COGNITIVE IMPAIRMENT ASSOCIATED WITH POST-COVID-19 SYNDROME

Active, not recruitingCTIS2024-517199-39-00

Dr. Willmar Schwabe GmbH & Co. KGCOGNITIVE IMPAIRMENT ASSOCIATED WITH POST-COVID-19 SYNDROME

Start: 2025-03-19Target: 400Updated: 2026-01-19

Phase 3

Obicetrapib and Cardiovascular Outcomes: A Placebo-Controlled, Double-Blind, Randomized Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease (ASCVD) Who are Not Adequately Controlled Despite Maximally Tolerated Lipid-Modifying Therapies

Active, not recruitingCTIS2023-507795-51-00

NewAmsterdam Pharma B.V.atherosclerotic heart and blood vessel disease (the narrowing of arteries from buildup of plague

Start: 2022-05-17Target: 4094Updated: 2026-01-27